Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/11262
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Waugh, R. | - |
dc.contributor.author | Steinborner, S. | - |
dc.contributor.author | Bowie, J. | - |
dc.contributor.author | Wallace, J. | - |
dc.contributor.author | Tyler, M. | - |
dc.contributor.author | Hu, P. | - |
dc.contributor.author | Gross, M. | - |
dc.date.issued | 1995 | - |
dc.identifier.citation | Australian Journal of Chemistry: an international journal for chemical science, 1995; 48(12):1981-1987 | - |
dc.identifier.issn | 0004-9425 | - |
dc.identifier.issn | 1445-0038 | - |
dc.identifier.uri | http://hdl.handle.net/2440/11262 | - |
dc.description.abstract | <jats:p>Three related peptides, caeridins 1.1-1.3, have been isolated from the green tree frog Litoria gilleni. Caeridins 1.1 and 1.2 are dodecapeptides differing only in having α and β Asp at residue 4 [viz. Gly Leu Leu Asp Gly Leu Leu Gly Thr Leu Gly Leu (NH2)]. Caeridin 1.3 is the corresponding cyclic amino succinyl derivative derived formally by cyclization of Asp(4) and Gly (5). Hydrolysis of caeridin 1.3 yields caeridin 1.1 and 1.2 in the ratio 3:1. This constitutes a rare case of the isolation of three such related peptides from a natural system. </jats:p> | - |
dc.description.uri | http://www.publish.csiro.au/nid/51/paper/CH9951981.htm | - |
dc.language.iso | en | - |
dc.publisher | CSIRO | - |
dc.source.uri | http://dx.doi.org/10.1071/ch9951981 | - |
dc.title | Two isomeric a and b aspartyl dodecapeptides and their cyclic amino succinyl analogues from the Australian Green Tree Frog Litoria gilleni | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1071/CH9951981 | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest 2 Biochemistry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.